• AM251 as a CB1 Receptor Antagonist: Protocols and Insights

  2026-05-12

  AM251, a potent CB1 receptor antagonist from APExBIO, empowers cannabinoid receptor research with unmatched specificity and utility. This guide provides actionable workflows, troubleshooting advice, and experimental strategies for leveraging AM251 across neuropharmacology and metabolic research models.

• HyperTrap Heparin HP Column: Precision Protein Purification

  2026-05-11

  Harness the HyperTrap Heparin HP Column for high-resolution isolation of growth factors and signaling molecules pivotal in breast cancer stemness. Discover streamlined workflows, robust troubleshooting, and advanced applications that set APExBIO’s chromatography platform apart for translational cancer biology.

• Arrb2 in Hepatocytes Induces M2 Polarization to Reduce Liver

  2026-05-11

  This study uncovers a hepatocyte-specific mechanism where Arrb2 upregulates the metabolite 6-ketoLCA, leading to increased M2 macrophage polarization and reduced hepatic ischemia–reperfusion injury (IRI). The findings clarify a new immunometabolic axis relevant for liver transplantation outcomes, offering a foundation for therapeutic targeting.

• Chlamydial Membrane Vesicles Deliver OmpA to Mitochondria to

  2026-05-10

  This study demonstrates that Chlamydia trachomatis uses membrane vesicles to transport its outer membrane protein OmpA to host mitochondria, where OmpA inhibits apoptosis by interacting with BCL-2 family effectors. The findings reveal a sophisticated bacterial strategy for subverting host cell death, providing new mechanistic insights into host-pathogen interactions and mitochondrial apoptosis regulation.

• Triacetin (Glyceryl Triacetate): Mechanisms, Evidence, and R

  2026-05-09

  Triacetin (glyceryl triacetate) is a metabolically active, synthetic triglyceride compound with proven utility as a lipid-related biochemical reagent and apoptosis inducer in glioblastoma models. Evidence supports its rapid hydrolysis to acetate and glycerol, mediating AMPK activation and lipid metabolism modulation. APExBIO’s BA1710 formulation enables reliable integration into advanced life science assays.

• KU-55933: ATM Kinase Inhibitor for DNA Damage Response Resea

  2026-05-09

  KU-55933 stands out as a potent, selective ATM kinase inhibitor, enabling researchers to dissect DNA damage response pathways with precision. This article translates advanced findings into actionable protocols, highlighting workflow enhancements, troubleshooting, and the broad utility of KU-55933 in cancer research and genome integrity studies.

• ML133 HCl: Precision Potassium Channel Inhibitor for PASMC R

  2026-05-08

  ML133 HCl empowers researchers to dissect Kir2.1 channel function in pulmonary artery smooth muscle cell (PASMC) models with unrivaled selectivity. Its robust inhibition profile and workflow compatibility accelerate cardiovascular ion channel research and disease modeling.

• Effector Caspases Drive Autophagy and DNA Repair in Breast C

  2026-05-07

  This study uncovers a non-apoptotic role for caspase 3 and caspase 7 in promoting cytoprotective autophagy and facilitating DNA damage responses under non-lethal stress in human breast cancer cells. These findings broaden our understanding of cell stress adaptation mechanisms and open new avenues for targeted cancer therapy research.

• Pemetrexed Disodium: Mechanistic Insights and Precision Onco

  2026-05-07

  Explore how pemetrexed disodium, a potent antifolate antimetabolite, advances cancer chemotherapy research through multi-enzyme inhibition and evidence-based applications in tumor models. This article bridges molecular pharmacology with practical assay design, providing unique, actionable insights for researchers.

• AO/PI Staining Solution: Precision Fluorescent Cell Counting

  2026-05-06

  AO/PI Staining Solution empowers researchers to achieve accurate, interference-free live/dead cell discrimination in fluorescence-based assays. Its dual fluorescent DNA dye system surpasses traditional viability methods, streamlining workflows for disease modeling and apoptosis studies.

• Epinephrine Bitartrate: Applied Workflows in Adrenergic Rese

  2026-05-06

  Unlock reproducible, high-sensitivity adrenergic assays with Epinephrine Bitartrate. This guide translates cutting-edge pharmacokinetic insights and real-world troubleshooting into actionable workflows for cardiovascular and neurobiology research.

• Triacetin in Translational Research: Mechanisms and Next Ste

  2026-05-05

  This article explores Triacetin’s mechanistic foundations, experimental validation, and translational potential as a lipid-related biochemical reagent. Integrating evidence-backed guidance and strategic context, it positions APExBIO’s Triacetin as a transformative tool for researchers targeting glioblastoma, metabolic regulation, and anti-adipogenesis. The discussion bridges molecular insight with protocol guidance, critically referencing peer-reviewed breakthroughs while mapping future directions for epigenetic and metabolic research.

• HyperScript III RT SuperMix: High-Fidelity cDNA Synthesis fo

  2026-05-05

  HyperScript III RT SuperMix enables high-yield, accurate cDNA synthesis for gene expression analysis by qPCR. Its advanced enzyme formulation ensures efficient reverse transcription of low-concentration and high-GC RNA templates, while integrated gDNA wiper mix minimizes genomic contamination. This product supports reproducible results in translational oncology and precision biomarker research.

• JC-1: Optimizing Mitochondrial Membrane Potential Assays

  2026-05-04

  JC-1, or 5,6-dichloro-2-[(E)-3-(5,6-dichloro-1,3-diethylbenzimidazol-3-ium-2-yl)prop-2-enylidene]-1,3-diethylbenzimidazole iodide, delivers dual-emission, ratiometric analysis for mitochondrial membrane potential in live-cell models. By leveraging JC-1 from APExBIO, researchers can enhance apoptosis detection, investigate mitochondrial dysfunction, and streamline troubleshooting in high-impact cellular bioenergetics studies.

• Proliferation Tracing in Mouse Models Reveals Mechanisms of

  2026-05-04

  This study introduces a dual recombinase genetic system in MMTV-PyMT transgenic mice to precisely trace and ablate proliferating breast cancer cells, enabling robust modeling of tumor relapse. Single-cell transcriptomic analyses uncover the cellular and microenvironmental heterogeneity driving recurrence, providing a valuable resource for mechanistic studies and therapeutic testing.

443 records 18/30 page Previous Next First page 上5页 1617181920 下5页 Last page